| Goggins, Michael G. |
Johns Hopkins University
United States |
Using markers to improve pancreatic cancer screening and surveillance: a multi-center study |
5U01CA210170-07 |
|
Matthew Young, Ph.D. |
| Paulson, Thomas G |
Fred Hutchinson Cancer Center
United States |
The microbiome ecosystem of Barrett's esophagus and progression to cancer |
5R21CA259687-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Matthew Young, Ph.D. |
| Wu, Yun |
State University Of New York At Buffalo
United States |
Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection |
5R21CA267934-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Matthew Young, Ph.D. |
| Carter, Bob S |
Massachusetts General Hospital
United States |
Standardized Molecular Analyses of Glioma EVs |
5R01CA237500-04 |
|
Matthew Young, Ph.D. |
| Majumder, Shounak |
Mayo Clinic Rochester
United States |
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer |
5U01CA210138-07 |
|
Matthew Young, Ph.D. |
| Goldman, Radoslav |
Georgetown University
United States |
O-glycoproteins in the progression of liver disease |
5R01CA238455-05 |
|
Matthew Young, Ph.D. |
| Esserman, Laura J |
University Of California, San Francisco
United States |
Extending the Diversity, Reach, and Generalizability of the WISDOM Study |
5R01CA237533-05 |
|
Claire Zhu, Ph.D. |
| Davis, Jennifer Sarah |
University Of Kansas Medical Center
United States |
Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype |
7U01CA222163-04 |
|
Claire Zhu, Ph.D. |
| Ghobrial, Irene M. |
Dana-Farber Cancer Inst
United States |
Molecular prediction of myeloma in African Americans |
5U01CA271492-02 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
Claire Zhu, Ph.D. |
| Skates, Steven J |
Massachusetts General Hospital
United States |
Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls |
5U01CA260758-03 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
Claire Zhu, Ph.D. |